Have you been diagnosed with endometriosis? If so, you have an opportunity to explore improved treatment options and also earn extra money participating in an FDA-licensed and approved clinical study.
It’s easy… it’s convenient… and it’s open to you if you are 18 years or older.
As a study participant, you play a valuable role in helping to get safe, effective drugs approved for public use.
Because you are such an important part of our studies, we have simplified the steps for participation.
This is the first step. All volunteers will be able to review the Informed Consent form, and the program will be carefully explained by our professional medical team.
After evaluating your particular medical situation, we will invite you into our clinic for a comprehensive and complimentary physical exam.
If you meet the physical guidelines of the study, you will be asked to participate. No insurance, social security number or proof of citizenship is required.
Participants will be assigned to different groups, where you will be carefully monitored for treatment and safety. As a volunteer, you will earn up to $1,300.
This professional clinical study, conducted by Hope Clinical Research, isshort-termerm trial in which you will intake a promising new medication seeking FDA approval. Depending on the study you join, this medication’s use is intended to effectively treat your medical condition.
The endometriosis study is a phase 2 study which means that the Phase 1 study was very promising and the FDA has approved the study to move to phase 2. Phase 1 study included human participants and saw limited adverse reaction issues. Hope Clinical Research has been selected to participate in phase 2 study due to its leading capabilities to provide great patient care in accordance with the FDA guidelines and study protocol.
Here is what you can expect, regarding these studies:
Hope Clinical Research has extensive experience conducting Phase II through IV clinical trials with many leading pharmaceutical companies. The facility’s lead investigator, Dr. Hessam Aazami, features many years in clinical research and counts over 8,000 patients in his current practice. Every member of the team offers a wealth of experience, a caring personality and a commitment to ably serving the pharmaceutical industry, the community and its patients.
Your information is private and secure. It will not be shared or spammed.
Complete the short form below